Lunch Program: Can SuperSaturated Oxygen (SSO2) Therapy Stem the Tide of Heart Failure?
Despite advances in reperfusion with primary stenting, STEMI outcomes have stagnated over the past 20 years, with 1 in 5 patients developing heart failure at 1 year. Hear global thought leaders discuss the rationale and science behind STEMI outcomes and what needs to be done to improve them. Learn about SSO2 Therapy and how it reduces infarct size in STEMI patients and hear about experiences with the therapy.